Documentos de Académico
Documentos de Profesional
Documentos de Cultura
ARTERIAL
DEFINICIN
sustained elevation of systemicarterialblood pressure,most
commonly definedas systolic blood pressure (SBP) 140 mm
Hg or diastolic blood pressure (DBP) 90 mm Hg
DIAGNOSTICO
Diagnosis ofhypertensionshould be based on 2 blood pressure
measurements per visit on 2 visits (ESH/ESC Class I, Level C)(4)
DEFINICIN Y
CLASIFICACIN
CRISIS HIPERTENSIVAS
Las crisis hipertensivas se definen como una elevacin aguda de la
presin arterial capaz de llegar a producir alteraciones
estructurales o funcionales en diferentes rganos.
Crisis hipertnsiva: Pacientes con PAS> 179 PAD> 109 mmHg.
JNC 7.
ESTRATIFICACIN DE
RIESGO
TOMA DE LA PRESIN
ARTERIAL EN CONSULTA
DX DIFERENCIALES
DX DIFERENCIALES
TRATAMIENTO
NICE
El diagnstico de HTA primaria o esencial debe ser confirmado
con MAPA o AMPA como gold standard
NICE
Media de la MAPA o
AMPA:
< 80 aos: < 135/85
> 80 aos: < 145/85
ESH/ESC GUIDELINES
JAMA RECOMENDACIONES
In General nonblack population, including those with diabetes
Initial antihypertensive treatment should include any of the
following:
A thiazide-type diuretic
Calcium channel blocker (CCB)
Angiotensin-converting enzyme inhibitor (ACEI) or
Angiotensin receptor blocker (ARB).
JAMA RECOMENDACIONES
In general black population, including those with
diabetes:
Initial antihypertensive treatment should include :
Thiazide-type diuretic
CCB.
JAMA RECOMENDACIONES
Population aged 18 years or older with CKD and
hypertension
JAMA RECOMENDACIONES
EN RESUMEN:
No Raza Negra / <55aos / ERC / DM /
Coronary artery diseases
IECA:
CCB:
Thiazidas:
EN RESUMEN:
Hipertensin con Angina de Pecho:
B-bloquers: metoprolol (50 1 mg/d), atenolol (25
100 mg/d)
CCB
Hipertension con embarazo:
Metildopa (250 mg/3vces dia)
B-bloquers
CCB
EN RESUMEN:
Aspirin
low-dose aspirin suggested in patients withhypertensionat
high risk for cardiovascular disease
for primary prevention of cardiovascular disease in patients
withhypertension, aspirin reduces myocardial infarction,
increases bleeding, and does not reduce strokes or total
cardiovascular events
EN RESUMEN:
considerstatinsfor patients
cardiovascular disease
at
increased
risk
for